Lv5
990 积分 2026-08-05 加入
Antibody-drug conjugates: unpacking toxicity profiles and optimized designs for enhanced safety and antitumor efficacy
4小时前
待确认
A modular framework for antibody–drug conjugate biomarkers
4小时前
待确认
Targeted degrader conjugates (TDCs): Modalities for precision delivery of PROTACs and molecular glue degraders
4小时前
待确认
Receptor-Guided Targeted Protein Degradation Collapses Extracellular Vesicle-Driven Tumor-Stroma Crosstalk
4小时前
待确认
Exploring the immunological effects of antibody–drug conjugates
5小时前
待确认
Bioorthogonal chemistry conjugates: ADCs and beyond
5小时前
待确认
Recent immunoglobulin G1 engineering strategies to modulate immune effector functions for therapeutics
8天前
已完结
STING reprogramming by estrogen promotes neutrophil extracellular trap formation and sex-biased resistance to ADC therapy
9天前
已完结
Regulatory and Quality Considerations of Antibody-drug Conjugates
13天前
已完结
Harnessing the E3 Ligase KLHL12 for Tumor‐Selective Protein Degradation
14天前
已完结
皖公网安备34019202002308
